供应商管理岗

上海济煜医药科技股份有限公司

Chinese pharmaceutical company founded on 22 June 2018 in the Pudong New Area of Shanghai with Li Xin as legal representative, focused on the research, manufacture and commercial translation of innovative medicines. Works to a clinical value led strategy across a three plus one indication matrix covering oncology, kidney disease, pain and autoimmune disease, and has built a research system spanning basic research, preclinical study, clinical development, pharmacovigilance and new drug registration and launch. Runs several advanced technology platforms in both biologics and small molecules with more than forty programmes in development, of which nineteen have entered clinical stage in China or abroad, and its registered scope also covers technology development, consulting, service and transfer in pharmaceutical and biological science, drug research, medical device trading and goods and technology import and export.